시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 샘플 요청 목록
세계의 아데노신 삼인산(Adenosine Triphosphate) 분석 시장 보고서(2025년)
Adenosine Triphosphate (ATP) Assays Global Market Report 2025
상품코드 : 1821710
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ￦ 6,487,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ￦ 9,376,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ￦ 12,266,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

아데노신 삼인산 분석 시장 규모는 향후 수년간 급성장할 것으로 전망됩니다. 2029년에는 CAGR 11.9%를 나타내 34억 4,000만 달러로 성장할 전망입니다. 예측 기간의 성장은 바이오 의약품 산업의 지속적인 성장, 개인화된 의료 접근법의 확대, 식품 및 식품 안전의 중요성 증가, 분석 플랫폼의 기술 혁신, 산업 공정에서의 응용 확대 등에 기인할 수 있습니다. 예측 기간의 주요 동향으로는 ATP 검출기술의 진보, 고처리량 스크리닝 수요 증가, 임상진단에의 통합, 식음료안전시험의 중시, 스포츠나 퍼포먼스 모니터링에의 응용 등이 있습니다.

향후 5년간의 성장률 11.9%라는 예측은 전회 예측으로부터 0.2%의 소폭의 감소를 반영하고 있습니다. 이 감소는 주로 미국과 타국 간의 관세의 영향 때문입니다. 관세 장벽은 독일과 한국에서 공급되는 고감도 ATP 검출 키트의 비용을 상승시키고, 연구 검증을 늦추고, 임상 실험실의 운영 비용을 증가시킴으로써 미국의 생명공학 부문을 방해할 것으로 예측됩니다. 또한 상호관세와 무역의 긴장과 한계 증가로 인한 세계경제와 무역에 대한 악영향으로 인해 그 영향이 더욱 광범위해질 것으로 보입니다.

암, 만성 질환, 감염증의 이환율 상승이 아데노신 삼인산 분석 시장의 향후 성장을 견인할 것으로 예측됩니다. 암은 통제 불가능한 세포 증식을 특징으로 하며, 이웃 조직에 침투하여 손상을 입히고 신체의 다른 부위로 전이할 수 있습니다. 만성 질환은 일반적으로 천천히 발생하고 장기간 지속되는 안정한 상태입니다. 감염은 박테리아, 바이러스, 곰팡이, 기생충 등 사람에서 사람으로 감염되는 병원성 미생물에 의해 유발됩니다. ATP 분석은 세포 생존 능력 평가, 미생물 오염 검출, 치료 효과 평가, 대사 및 미토콘드리아 기능 장애의 모니터링을 통해 이러한 질병의 중요한 진단 도구 역할을 합니다. 예를 들어 2024년 2월 스위스에 본부를 두는 유엔기관인 세계보건기구(WHO)는 2050년까지 새롭게 발생하는 암 환자는 3,500만명을 넘어 2022년 추정 2,000만명에서 77% 증가할 것으로 예측했습니다. 게다가 2021년 벨기에에 본부를 둔 당뇨병 공동체에 초점을 맞춘 조직인 국제 당뇨병 연합은 약 5억 3,700만 명의 성인이 당뇨병을 앓고 있다고 보고했으며, 그 수는 2045년까지 7억 8,300만 명으로 증가할 것으로 예상했습니다. 따라서 암, 만성질환, 감염증의 유병률 증가가 아데노신 삼인산 분석 시장을 견인하고 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

제36장 부록

KTH
영문 목차

영문목차

ATP assays, or adenosine triphosphate assays, serve as analytical procedures to determine ATP concentrations in biological materials. ATP, an energy-carrying molecule present in cells of all living organisms, extracts chemical energy from the breakdown of food molecules and utilizes it to power various cellular functions. This assay plays a crucial role in monitoring cellular energy state and function, serving as a vital tool in research, diagnostics, and drug discovery.

The primary types of ATP assays include luminometric ATP assays, enzymatic ATP assays, bioluminescence resonance energy transfer (BRET) ATP assays, cell-based ATP assays, among others. Luminometric ATP assays, specifically, leverage bioluminescence principles to measure ATP levels in samples. They are widely used in research, drug discovery, and biomedical applications for assessing cellular energy status, measuring enzymatic activity, evaluating cell viability, and screening ATP-modulating compounds. These assays consist of essential components such as consumables, accessories, and instruments utilized across diverse fields including drug discovery and development, clinical diagnostics, environmental testing, and food safety and quality assessment. Their applications extend to various end-users such as pharmaceutical and biotechnology companies, the food and beverage industry, hospitals, diagnostics laboratories, as well as academic and research institutions.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The adenosine triphosphate (ATP) assays market research report is one of a series of new reports from The Business Research Company that provides adenosine triphosphate (ATP) assays market statistics, including adenosine triphosphate (ATP) assays industry global market size, regional shares, competitors with an adenosine triphosphate (ATP) assays market share, detailed adenosine triphosphate (ATP) assays market segments, market trends and opportunities, and any further data you may need to thrive in the adenosine triphosphate (ATP) assays industry. This adenosine triphosphate (ATP) assays market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The adenosine triphosphate (atp) assays market size has grown rapidly in recent years. It will grow from $1.99 billion in 2024 to $2.19 billion in 2025 at a compound annual growth rate (CAGR) of 10.5%. The growth in the historic period can be attributed to biomedical research advancements, drug discovery and development, rise in adoption in clinical diagnostics, environmental monitoring requirements, increased focus on cell-based assays.

The adenosine triphosphate (atp) assays market size is expected to see rapid growth in the next few years. It will grow to $3.44 billion in 2029 at a compound annual growth rate (CAGR) of 11.9%. The growth in the forecast period can be attributed to continued growth in biopharmaceutical industry, expansion of personalized medicine approaches, increased emphasis on food and beverage safety, technological innovations in assay platforms, growing application in industrial processes. Major trends in the forecast period include advancements in ATP detection technologies, rising demand for high-throughput screening, integration in clinical diagnostics, emphasis on food and beverage safety testing, application in sports and performance monitoring.

The forecast of 11.9% growth over the next five years reflects a slight reduction of 0.2% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff barriers are expected to hamper the U.S. biotech sector by increasing the cost of high-sensitivity ATP detection kits sourced from Germany and South Korea, thereby slowing research validation and elevating clinical lab operational costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The rising incidence of cancer, chronic diseases, and infectious diseases is projected to drive the growth of the adenosine triphosphate (ATP) assay market in the future. Cancer is marked by uncontrolled cell growth that can invade and damage nearby tissues and may spread to other parts of the body. Chronic diseases are stable conditions that generally develop slowly and persist over a long period. Infectious diseases are caused by pathogenic microorganisms that can be transmitted from one person to another, including bacteria, viruses, fungi, or parasites. ATP assays serve as an important diagnostic tool for these diseases by evaluating cellular viability, detecting microbial contamination, assessing treatment effectiveness, and monitoring metabolic and mitochondrial dysfunction. For example, in February 2024, the World Health Organization, a United Nations agency based in Switzerland, projected that over 35 million new cancer cases will occur by 2050, representing a 77% increase from an estimated 20 million cases in 2022. Additionally, in 2021, the International Diabetes Federation, a Belgium-based organization focused on the diabetic community, reported that approximately 537 million adults have diabetes, with that number expected to rise to 783 million by 2045. Therefore, the growing prevalence of cancer, chronic, and infectious diseases is driving the ATP assay market.

The growing demand for personalized treatment approaches is expected to fuel the expansion of the adenosine triphosphate (ATP) assays market. Personalized treatments involve utilizing knowledge about an individual's unique genetic or protein makeup to prevent, detect, or treat diseases effectively. In the context of infectious disease management, ATP assays play a crucial role by assessing the efficacy of antimicrobial agents against specific pathogens, aiding in the selection of personalized treatment strategies. For instance, the US Food and Drug Administration (FDA) approved 12 personalized medicines in 2022, constituting around 34% of all newly approved therapeutic molecular entities, as reported by the Personalized Medicine Coalition. This surge in demand for personalized medicine underscores its pivotal role in driving the growth of the adenosine triphosphate (ATP) assays market.

The rising prevalence of chronic diseases is projected to drive the growth of the adenosine triphosphate (ATP) assays market in the coming years. Chronic diseases are illnesses that persist for three months or longer and can worsen over time. Several factors contribute to the increasing prevalence of these conditions, including an aging population, unhealthy lifestyle choices, and rapid urbanization, which lead to a rise in diseases such as diabetes, cardiovascular disease, and respiratory illnesses. ATP, the main energy carrier in cells, is measured through ATP assays to investigate disruptions in cellular energy metabolism, which are often linked to chronic diseases like diabetes, cancer, and neurodegenerative disorders. This understanding helps researchers better comprehend disease progression and develop new therapeutic strategies. For example, in February 2024, the World Health Organization, a United Nations agency based in Switzerland, projected that over 35 million new cancer cases will be diagnosed by 2050, representing a 77% increase from the estimated 20 million cases in 2022. Consequently, the growing prevalence of chronic diseases is fueling the expansion of the ATP assays market.

The evolution of novel assays stands out as a prominent trend gaining momentum within the adenosine triphosphate (ATP) assay market. Key companies operating in this domain are introducing groundbreaking products, such as the SensiLux kit by BC Aplicaciones, a biotechnology firm based in Spain. The SensiLux kit is a unique testing solution designed for detecting microbial ATP in samples, utilizing bioluminescence for detection following sample pre-incubation. Its applications extend to areas such as food safety and contamination testing. Additionally, this offering includes ATP kits featuring advanced multi-injector automatic luminometers, proprietary control software, and future-oriented robot-based sample automation, providing customers with tailored solutions. BC Aplicaciones' programming and computer systems department have developed unique software to manage robot and luminometer operations.

Leading companies in the adenosine triphosphate (ATP) assays market are concentrating on creating advanced kinase testing platforms to offer highly sensitive assays. A kinase testing platform is a specialized system designed to assess kinase activity in biological samples, supporting drug discovery and development by providing insights into kinase function and inhibition. For example, in April 2024, Reaction Biology, a biotechnology firm based in the U.S., launched the HotSpot(TM) ATP-Max KinomeScreen, an advanced assay for high-throughput kinase screening that features enhanced sensitivity, allowing testing at ATP levels as low as 1 mM. This innovative platform utilizes a gold standard filter binding radiometric assay to assess kinase activity across the broadest range of kinase targets in the industry. By providing physiologically relevant data, the HotSpot ATP-Max KinomeScreen enables researchers to identify more potent and specific kinase inhibitors, thereby advancing drug discovery efforts and aiding the development of targeted therapies for various diseases, particularly cancer.

Major companies operating in the adenosine triphosphate (ATP) assays market include Merck KGaA, Thermo Fisher Scientific Inc., PerkinElmer Inc., Lonza Group, Promega Corporation, Agilent Technologies Inc., Abcam plc, Danaher Corporation, 3M Co., Geno Technology Inc., NEOGEN Corporation, Biomerieux SA, AAT Bioquest Inc., MBL International Corporation, Charm Sciences Inc., Cell Signaling Technology Inc., Cayman Chemical Company, Vazyme Biotech Co. Ltd., SignalChem Lifesciences Corporation, Kaneka Corporation, Novus Biologicals LLC, NANOGEN Biotechnologies Inc., Nacalai Tesque Inc., MoBiTec GmbH, Lumigen Inc., Jena Bioscience GmbH, Goryo Chemical Inc., Cosmo Bio Co. Ltd., BPS Bioscience Inc., BioTek Instruments Inc.

North America was the largest region in the adenosine triphosphate (ATP) assays market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the adenosine triphosphate (atp) assays market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the adenosine triphosphate (atp) assays market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The adenosine triphosphate (ATP) assays market consists of revenues earned by entities by providing testing services related to colorimetric and fluorescent assays. The market value includes the value of related goods sold by the service provider or included within the service offering. The adenosine triphosphate (ATP) assays market also includes sales of luminometer, and chemiluminescent which are used in adenosine triphosphate (ATP) assay services. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Adenosine Triphosphate (ATP) Assays Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on adenosine triphosphate (atp) assays market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for adenosine triphosphate (atp) assays ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The adenosine triphosphate (atp) assays market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Adenosine Triphosphate (ATP) Assays Market Characteristics

3. Adenosine Triphosphate (ATP) Assays Market Trends And Strategies

4. Adenosine Triphosphate (ATP) Assays Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Adenosine Triphosphate (ATP) Assays Growth Analysis And Strategic Analysis Framework

6. Adenosine Triphosphate (ATP) Assays Market Segmentation

7. Adenosine Triphosphate (ATP) Assays Market Regional And Country Analysis

8. Asia-Pacific Adenosine Triphosphate (ATP) Assays Market

9. China Adenosine Triphosphate (ATP) Assays Market

10. India Adenosine Triphosphate (ATP) Assays Market

11. Japan Adenosine Triphosphate (ATP) Assays Market

12. Australia Adenosine Triphosphate (ATP) Assays Market

13. Indonesia Adenosine Triphosphate (ATP) Assays Market

14. South Korea Adenosine Triphosphate (ATP) Assays Market

15. Western Europe Adenosine Triphosphate (ATP) Assays Market

16. UK Adenosine Triphosphate (ATP) Assays Market

17. Germany Adenosine Triphosphate (ATP) Assays Market

18. France Adenosine Triphosphate (ATP) Assays Market

19. Italy Adenosine Triphosphate (ATP) Assays Market

20. Spain Adenosine Triphosphate (ATP) Assays Market

21. Eastern Europe Adenosine Triphosphate (ATP) Assays Market

22. Russia Adenosine Triphosphate (ATP) Assays Market

23. North America Adenosine Triphosphate (ATP) Assays Market

24. USA Adenosine Triphosphate (ATP) Assays Market

25. Canada Adenosine Triphosphate (ATP) Assays Market

26. South America Adenosine Triphosphate (ATP) Assays Market

27. Brazil Adenosine Triphosphate (ATP) Assays Market

28. Middle East Adenosine Triphosphate (ATP) Assays Market

29. Africa Adenosine Triphosphate (ATP) Assays Market

30. Adenosine Triphosphate (ATP) Assays Market Competitive Landscape And Company Profiles

31. Adenosine Triphosphate (ATP) Assays Market Other Major And Innovative Companies

32. Global Adenosine Triphosphate (ATP) Assays Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Adenosine Triphosphate (ATP) Assays Market

34. Recent Developments In The Adenosine Triphosphate (ATP) Assays Market

35. Adenosine Triphosphate (ATP) Assays Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기